Healthcare / Diagnostics & ResearchUpdated 2026-05-10 22:07 UTC

TPEX/1784 stock hub

TPEX/1784 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TPEX/1784is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

3.7B

Taipei Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TPEX/1784

In the news

Latest news · TPEX/1784

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12P50 15.5P75 22.5

Trailing P/E71.2

P25 14.4P50 18P75 31.9

ROE0

P25 -16.2P50 0.3P75 9.8

ROIC-0.1

P25 -11.7P50 -0.2P75 8.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TPEX/1784 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

234

Groups with data

Currency

TWD

Showing 234 of 234 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Enterprise value	TWD 3.4B
Exchange	Taipei Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Diagnostics & Research
Isin	TW0001784007
Last refreshed	2026-05-10
Market cap	TWD 3.7B
Price	TWD 72.6
Price currency	TWD
Sector	Healthcare
Sic	2836
Symbol	tpex/1784
Website	https://www.bionetcorp.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.41%
EV Earnings	65.15x
EV/EBITDA	70x
EV/FCF	137.21x
EV/Sales	2.71x
FCF yield	0.67%
P/B ratio	1.62x
P/E ratio	71.18x
P/S ratio	2.95x
PE Ratio10 Y	121.1x
PE Ratio3 Y	57.55x
PE Ratio5 Y	66.53x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-1.17%
EBITDA Margin	3.87%
FCF margin	1.97%
Gross margin	55.3%
Gross Profit	TWD 683.9M
Gross Profit Growth	-0.28%
Gross Profit Growth Q	1.6%
Gross Profit Growth3 Y	8.04%
Gross Profit Growth5 Y	10.67%
Net Income	TWD 51.4M
Net Income Growth	-38.56%
Net Income Growth Q	-55.57%
Net Income Growth Years	0%
Net Income Growth3 Y	10.64%
Net Income Growth5 Y	32.19%
Pretax Margin	1.56%
Profit Margin	4.16%
Profitable Years	7
ROA	-0.29
Roa5y	1.35
ROCE	-0.54
ROE	0.04
Roe5y	3.07
ROIC	-0.07
Roic5y	3.88

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	11.34%
Cagr15y	3%
Cagr1y	1.74%
Cagr20y	8.63%
Cagr3y	4.75%
Cagr5y	15.62%
Div CAGR10	8.47%
Div CAGR3	10.28%
Div CAGR5	38.29%
EPS Growth	-38.18
EPS Growth Q	-55.54
EPS Growth Years	0
EPS Growth3 Y	10.94
EPS Growth5 Y	32.43
FCF Growth	-67.51%
FCF Growth3 Y	-28.13%
FCF Growth5 Y	-12.21%
OCF Growth	-16.12%
OCF Growth Q	-52.26%
OCF Growth10 Y	15.46%
OCF Growth3 Y	16.08%
OCF Growth5 Y	14.98%
Revenue Growth	1.19x
Revenue Growth Q	4.43x
Revenue Growth Quarters	1x
Revenue Growth Years	6x
Revenue Growth3 Y	8.05x
Revenue Growth5 Y	8.92x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0.4
Assets	TWD 3.1B
Cash	TWD 1.4B
Current Assets	TWD 1.9B
Current Liabilities	TWD 405.1M
Debt	TWD 113.8M
Debt EBITDA	TWD 2.38
Debt Equity	TWD 0.05
Debt FCF	TWD 4.66
Equity	TWD 2.3B
Interest Coverage	-9.64
Liabilities	TWD 822.6M
Long Term Assets	TWD 1.2B
Long Term Liabilities	TWD 417.5M
Net Cash	TWD 1.3B
Net Cash By Market Cap	TWD 35.24
Net Cash Growth	-13.05%
Net Debt EBITDA	TWD -26.89
Net Debt Equity	TWD -0.57
Net Debt FCF	TWD -52.71
Tangible Book Value	TWD 1.2B
Tangible Book Value Per Share	TWD 24.76
WACC	7.13

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.62
Inventory Turnover	5.34
Net Working Capital	TWD 147.7M
Quick ratio	4.22
Working Capital	TWD 1.5B
Working Capital Turnover	TWD 0.81

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.83%
Dividend Growth	-38.4%
Dividend Growth Years	5%
Dividend per share	TWD 1.42
Dividend Years	8
Dividend Yield	1.95%
Ex Div Date	2026-10-01
Last Dividend	TWD 0.87
Payout Frequency	Annual
Payout Ratio	136.24%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	192.81%
1Y total return	1.74%
200-day SMA	87.84
3Y total return	14.94%
50-day SMA	83.16
50-day SMA vs 200-day SMA	50under200
5Y total return	106.6%
All Time High	201.1
All Time High Change	-63.89%
All Time High Date	2007-07-26
All Time Low	13.26
All Time Low Change	447.59%
All Time Low Date	2004-09-17
ATR	2.29
Beta	0.56
Beta1y	0.86
Beta2y	0.83
Ch YTD	-29.86
High	73.2
High52	118
High52 Date	2026-01-14
High52ch	-38.47%
Low	71.1
Low52	63.4
Low52 Date	2025-07-09
Low52ch	14.51%
Ma50ch	-12.7%
Price vs 200-day SMA	-17.35%
RSI	31.53
RSI Monthly	45.3
RSI Weekly	36.76
Sharpe ratio	0.28x
Sortino ratio	0.63
Total Return	2.78%
Tr YTD	-29.86
Tr15y	55.76%
Tr1m	-7.52%
Tr1w	-1.49%
Tr3m	-21.68%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	TWD -14.5M
Operating margin	-1.17

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	39,948,897%
Net Borrowing	-8,114,000
Shares Insiders	5.44%
Shares Institutions	1.66%
Shares Out	50,306,000
Shares Qo Q	-0.41%
Shares Yo Y	-0.83%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TWD 2,000
Average Volume	193,160.3x
Bv Per Share	25.37
CAPEX	TWD -123.6M
Ch10y	172.3
Ch15y	33.59
Ch1m	-7.52
Ch1w	-1.49
Ch20y	313.4
Ch3m	-21.68
Ch3y	11.07
Ch5y	96.58
Ch6m	-23.74
Change	0.97%
Change From Open	0.97
Close	71.9
Days Gap	0
Depreciation Amortization	62,333,000
Dollar Volume	12,261,486.6
Earnings Date	2026-05-12
EBIT	TWD -14.5M
EBITDA	TWD 47.9M
EPS	TWD 1.02
F Score	3
FCF	TWD 24.4M
FCF EV Yield	0.73x
FCF Per Share	TWD 0.49
Financing CF	-169,956,000
Fiscal Year End	December
Founded	1,989
Graham Number	24.13152
Graham Upside	-66.76
Income Tax	TWD 18.4M
Investing CF	35,366,000
Is Primary Listing	1
Last Earnings Date	2025-11-11
Last Report Date	2025-12-31
Last Split Date	2024-09-19
Last Split Type	Forward
Lynch Fair Value	TWD 25.5
Lynch Upside	-64.88
Ma150	91.98
Ma150ch	-21.07%
Ma20	77.1
Ma20ch	-5.83%
Net CF	13,255,000
Next Earnings Date	2026-05-12
Open	71.9
P FCF Ratio	149.6
P OCF Ratio	24.67
Payment Date	2026-10-30
Position In Range	71.43
Ppne	695,404,000
Price Date	2026-05-08
Price EBITDA	TWD 76.3
Ptbv Ratio	2.94
Relative Volume	0.88x
Revenue	1,236,596,000x
SBC By Revenue	1.97x
Share Based Comp	24,417,000
Tax By Revenue	1.49x
Tax Rate	95.6%
Tr20y	423.56%
Tr6m	-23.74%
Volume	168,891
Z Score	4.04

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

TPEX/1784 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.0%

$1.42 annual per share

Payout ratio

+136.2%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+38.3%

5 consecutive years of growth

Total shareholder yield

+2.8%

Next ex-dividend date: 2026-10-01

Performance

TPEX/1784 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TPEX/1784?

Insider, institutional, and short-interest positioning.

Institutional ownership

+1.7%

Share of float held by funds and institutions

Insider ownership

+5.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.8%

Negative means the company is buying back shares.

Technical

TPEX/1784 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

31.5

Neutral momentum band

Price vs 200-day MA

-17.3%

50/200-day relationship not available

Beta (5Y)

0.56

Less volatile than the market

Sharpe ratio

0.28

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TPEX/1784

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpex/1784 stock rating?

tpex/1784 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpex/1784 analysis?

The full report lives at /stocks/tpex/1784/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpex/1784?

The latest report frames tpex/1784 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpex/1784 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.